Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Platelet function inhibitors

Citations 221-230 of 251 total displayed.

Past content (since Oct 2000):

Clinical Investigations and Reports
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes
Marco Roffi, Derek P. Chew, Debabrata Mukherjee, Deepak L. Bhatt, Jennifer A. White, Christopher Heeschen, Christian W. Hamm, David J. Moliterno, Robert M. Califf, Harvey D. White, Neal S. Kleiman, Pierre Théroux, and Eric J. Topol
Circulation 2001;104:2767-2771, doi:10.1161/hc4801.100029 [Abstract] [Full text]  

Clinical Investigations and Reports
PlA2 Polymorphism of ß3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury
Anetta Undas, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2001;104:2666-2672, doi:10.1161/hc4701.099787 [Abstract] [Full text]  

Clinical Investigations and Reports
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Marvin A. Konstam, Matthew R. Weir, Alise Reicin, Deborah Shapiro, Rhoda S. Sperling, Eliav Barr, and Barry J. Gertz
Circulation 2001;104:2280-2288; published online before print as doi:10.1161/hc4401.100078 [Abstract] [Full text]  

Basic Science Reports
Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries
H. Vernon Anderson, Janice McNatt, Fred J. Clubb, Michael Herman, Jean-Pierre Maffrand, Fred DeClerck, Chul Ahn, L. Maximilian Buja, and James T. Willerson
Circulation 2001;104:2331-2337, doi:10.1161/hc4401.098434 [Abstract] [Full text]  

Basic Science Reports
Lipid Peroxidation and Platelet Activation in Murine Atherosclerosis
Tillmann Cyrus, Lina X. Tang, Joshua Rokach, Garret A. FitzGerald, and Domenico Praticò
Circulation 2001;104:1940-1945, doi:10.1161/hc4101.097114 [Abstract] [Full text]  

Clinical Investigations and Reports
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Marvin A. Konstam, Matthew R. Weir, Alise Reicin, Deborah Shapiro, Rhoda S. Sperling, Eliav Barr, and Barry J. Gertz
Circulation published October 15, 2001, doi:10.1161/hc4401.100078 [Abstract] [Full text]  

Correspondence
Clopidogrel Versus Aspirin After Cardiac Surgery Response
Freek W.A. Verheugt, Deepak L. Bhatt, Derek P. Chew, Eric J. Topol, Alan T. Hirsch, Werner Hacke, and Peter A. Ringleb
Circulation 2001;104:e76 [Full text]  

Clinical Investigations and Reports
Dissociation of Glycoprotein IIb/IIIa Antagonists From Platelets Does Not Result in Fibrinogen Binding or Platelet Aggregation
Andrew L. Frelinger, III, Mark I. Furman, Lori A. Krueger, Marc R. Barnard, and Alan D. Michelson
Circulation 2001;104:1374-1379, doi:10.1161/hc3701.095950 [Abstract] [Full text]  

Clinical Investigations and Reports
Abciximab Readministration: Results of the ReoPro Readministration Registry
James E. Tcheng, Dean J. Kereiakes, A. Michael Lincoff, Barry S. George, Neal S. Kleiman, David C. Sane, Douglas B. Cines, Robert E. Jordan, Mary Ann Mascelli, Mary Ann Langrall, Lakshmi Damaraju, Allen Schantz, Mark B. Effron, and Gregory A. Braden
Circulation 2001;104:870-875, doi:10.1161/hc3301.094533 [Abstract] [Full text]  

Clinical Investigations and Reports
Cerebral Autoregulatory Responses to Head-Up Tilt in Normal Subjects and Patients With Recurrent Vasovagal Syncope
Brian J. Carey, Bradley N. Manktelow, Ronney B. Panerai, and John F. Potter
Circulation 2001;104:898-902, doi:10.1161/hc3301.094908 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

* Subspecialty Collections Home

* Show  Platelet function inhibitors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors